» Articles » PMID: 12834315

Slower Progression of HIV-1 Infection in Persons with GB Virus C Co-infection Correlates with an Intact T-helper 1 Cytokine Profile

Overview
Journal Ann Intern Med
Specialty General Medicine
Date 2003 Jul 2
PMID 12834315
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Progression to AIDS is slower in persons infected with both HIV-1 and GB virus C (GBV-C), also known as hepatitis G virus.

Objective: To compare clinical, virologic, and immunologic variables in HIV-1-seropositive patients with and without GBV-C co-infection.

Design: Subanalysis of a prospective cohort study.

Setting: Institute of Infectious Diseases, University of Catania, Catania, Italy.

Patients: 80 asymptomatic HIV-1-seropositive patients.

Measurements: GBV-C RNA level; plasma HIV-1 viral load; CD4(+) cell counts; and serum levels of interleukin (IL)-2, IL-4, IL-10, and IL-12.

Results: At the start of the study, plasma GBV-C RNA was detected in 17 patients (21%). During follow-up, IL-2 and IL-12 levels decreased significantly (P = 0.005 and P = 0.01, respectively) and IL-4 and IL-10 levels increased significantly (P = 0.01 and P = 0.004, respectively) in the GBV-C-negative group but did not change substantially in the GBV-C-positive group. Each measured variable differed significantly between GBV-C-positive and GBV-C-negative groups during follow-up (P < 0.001 for IL-12, IL-4, and IL-10; P = 0.002 for IL-2).

Conclusion: GB virus C may immunologically interfere with progression of HIV-1 infection to AIDS by maintaining an intact T-helper 1 cytokine profile.

Citing Articles

Interplay between HIV and Human Pegivirus (HPgV) Load in Co-Infected Patients: Insights from Prevalence and Genotype Analysis.

Koksal M, Pirkl M, Sarsar K, Ilktac M, Horemheb-Rubio G, Yaman M Viruses. 2024; 16(1).

PMID: 38275941 PMC: 10820514. DOI: 10.3390/v16010005.


Surrogate Biomarkers of Disease Progression in Human Pegivirus Seropositive Human Immunodeficiency Virus-Infected Individuals.

Vimali J, Yong Y, Murugesan A, Ashwin R, Balakrishnan P, Raju S Viral Immunol. 2022; 36(1):55-62.

PMID: 36355180 PMC: 10024059. DOI: 10.1089/vim.2022.0144.


Human Pegivirus Type 1: A Common Human Virus That Is Beneficial in Immune-Mediated Disease?.

Stapleton J Front Immunol. 2022; 13:887760.

PMID: 35707535 PMC: 9190258. DOI: 10.3389/fimmu.2022.887760.


Review of human pegivirus: Prevalence, transmission, pathogenesis, and clinical implication.

Yu Y, Wan Z, Wang J, Yang X, Zhang C Virulence. 2022; 13(1):324-341.

PMID: 35132924 PMC: 8837232. DOI: 10.1080/21505594.2022.2029328.


Role of human Pegivirus infections in whole Plasmodium falciparum sporozoite vaccination and controlled human malaria infection in African volunteers.

Tumbo A, Schindler T, Dangy J, Orlova-Fink N, Bieri J, Mpina M Virol J. 2021; 18(1):28.

PMID: 33499880 PMC: 7837505. DOI: 10.1186/s12985-021-01500-8.